Journals / Van Tıp Dergisi / 2017 / Cilt: 24 - Sayı: 1

The Investigation of Impact of Stronsium Ranelat Application on Paraoxonase and Arylesterase Activities in Liver, Kidney and Muscle Tissues in Experimental Osteoporosis Rat Model

Deneysel Osteoporoz Modeli Oluşturulmuş Ratlarda Stronsiyum Ranelat Uygulanmasının Karaciğer, Böbrek ve Kas Dokularındaki Paraoksonaz ve Arilesteraz Aktivitelerine Etkisinin Araştırılması

Pages
12–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It can be concluded from this study that postmenopausal period and use of stronsium ranelat caused a decrease in PON and ARE activities in liver, kidney, and muscle tissues and therefore weakened the antioxidant system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we investigated the effect of stronsium ranelat, which is used extensively in the postmenopausal treatment, on paraoxonase and arylesterase in liver, kidney and muscle tissues of experimental osteoporosis rats.
📊
Key Findings & Data:Materials and Methods: 35 female Wistar Albino female rats were divided into 5 groups (7 animals in each group).
💡
Conclusion & Impact:Conclusion: It can be concluded from this study that postmenopausal period and use of stronsium ranelat caused a decrease in PON and ARE activities in liver, kidney, and muscle tissues and therefore weakened the antioxidant system.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we investigated the effect of stronsium ranelat, which is used extensively in the postmenopausal treatment, on paraoxonase and arylesterase in liver, kidney and muscle tissues of experimental osteoporosis rats. Materials and Methods: 35 female Wistar Albino female rats were divided into 5 groups (7 animals in each group). Group I was the control group, Group II received only stronsium ranelat, Group III underwent only oophorectomy, Group IV was consisted of rats in which stronsium ranelat treatment was started just after oophorectomy, and Group V consisted of rats in which stronsium ranelat treatment was started 3 months after oophorectomy. Liver, kidney, and muscle tissues of rats belonging to all groups were isolated and then PON and ARE activities were examined. The statistical differences in terms of PON and ARE values were evaluated by using ANOVA and Turkey Multiple Comparison for subgroups. Results: According to results obtained from this study, a statistically significant decrease in PON and ARE activities of liver, kidney and muscle of rats in all groups was determined compared to control group (p<0.05). Furthermore, a statistically significant decrease in PON and ARE activities was detected in Group V compared to Group II, Group III and Group IV (p<0.05). Conclusion: It can be concluded from this study that postmenopausal period and use of stronsium ranelat caused a decrease in PON and ARE activities in liver, kidney, and muscle tissues and therefore weakened the antioxidant system.

Özet

Amaç: Yaptığımız bu çalışmada deneysel osteoporoz modeli oluşturulan sıçanlarda, post-menopozal tedavide yaygın olarak kullanılan stronsiyum ranelatın karaciğer, böbrek ve kas dokularındaki paraoksonaz (PON) ve arilesteraz (ARE) enzim aktiviteleri üzerindeki etkisi araştırılmıştır. Gereç ve Yöntem: Bu çalışmada 35 adet dişi Wistar Albino sıçan kullanılmış ve her bir grupta 7 hayvan olacak şekilde 5 gruba ayrılmıştır. Bu gruplar kontrol grubu (Grup I), 3 ay boyunca sadece stronsiyum ranelat uygulanan grup (Grup II), sadece ooferektomi uygulanan grup (Grup III), ooferektomi sonra profilaktik amaçla hemen stronsiyum ranelat tedavisine başlanan grup (Grup IV) ve ooferektomi yapıldıktan 3 ay sonra stronsiyum ranelat tedavisine başlanan grup (Grup V) olarak belirlenmiştir. Tüm gruplardaki hayvanların karaciğer, böbrek ve kas dokuları izole edilerek PON ve ARE aktivitelerine bakılmıştır. PON ve ARE değerleri bakımından gruplar arasındaki istatistiksel farklılıklar ANOVA ve alt grup karşılaştırmalarında Tukey çoklu karşılaştırma testleri kullanılarak değerlendirilmiştir. Bulgular: Yaptığımız çalışmada tüm grupların karaciğer, böbrek ve kas PON ve ARE aktiviteleri kontrol grubuna kıyasla anlamlı ölçüde düşük olduğu tespit edilmiştir (p<0,05). Ayrıca Grup V'in karaciğer PON ve ARE aktivitelerinin Grup II, Grup III ve Grup IV'e göre anlamlı ölçüde yüksek olduğu tespit edilmiştir (p<0,05). Sonuç: Bulunan sonuçlar postmenopozal dönemin ve stronsiyum ranelat kullanımının karaciğer, böbrek ve kas dokularındaki PON ve ARE aktivitelerini azalttığını, dolayısıyla antioksidan sistemi zayıflattığını göstermektedir.

🔖

Cite This Article

BERKÖZ, M., SAĞIR, Ö., YALIN, S., ÇÖMELEKOĞLU, Ü., SÖĞÜT, F., EROĞLU, P. (2017). The Investigation of Impact of Stronsium Ranelat Application on Paraoxonase and Arylesterase Activities in Liver, Kidney and Muscle Tissues in Experimental Osteoporosis Rat Model. Van Tıp Dergisi, Cilt: 24 - Sayı: 1, 12–18. https://ajindex.com/articles/334013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Tüzün F. Osteoporozun tanımı, sınıflaması ve epidemiyolojisi. Sürekli Tıp Eğitimi Etkinlikleri, Osteoporoz Sempozyumu 1999; 9-15
  2. Eskiyurt N. Osteoporozda risk faktörleri. Prospect 1998; 2(3): 110-112
  3. Rosen CJ. Pathogenesis of osteoporosis. Bailliere's Clinical Endocrinology and Metabolizm 2000; 14(2): 180-193
  4. Dinçer G. Osteoporozda medikal tedavi yaklaşımları. Osteoporoz. Modern Tıp Seminerleri, 19. baskı, Ankara: Güneş Kitabevi 2001: 231-258
  5. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996; 18(6): 517-523
  6. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am JHum Genet 1983; 35(6): 1126-1138
  7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. JBiol Chem 1951; 193(1): 265-275
  8. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359(9319): 1761-1767
  9. Droge, W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82(1): 47-95
  10. Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B,Partington GA, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112(6): 915-923
  11. Muthusami S, Ramachandran I, Muthusamy B, Vasudevan G, Prabhu V, Subramaniam V, et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 2005; 360(1-2): 81-86
  12. Cavdaroglu B, Kose N, Baskol G, Demir H. Evaluation of protein and lipid oxidative stress in the patients with postmenopausal osteoporosis. Dicle Med J 2014; 41(1): 71-77
  13. Sorenson RC, Bisgaier CL, Aviram M, Hsu C, Billecke S, La dU BN. Human serum paraoxonase/arylesterase's retained hyrophobic Nterminal leader sequence associates with HDLs by binding phospholipids. Arterioscler Thromb Vasc Biol 1999; 19(9): 2214-2225
  14. Hatungil R, Yalin S, Comelekoglu U, Bagis S, Nayci A, Ogenler O, et al. Effect of calcitonin on lipid peroxidation in ovariectomized rats. Chinese J of Pathophysiology 2006; 22(supp. 13): 248
  15. Baskol G, Demir H, Cavdaroglu B. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with osteoporosis. Erciyes Medical Journal 2007; 29(4): 268-273
  16. Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 2003; 68(6): 373-378